The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer

por Buijs, S.M., Hoop, E. Oomen-de, Braal, C.L., van Rosmalen, M.M., Drooger, J.C., van Rossum-Schornagel, Q.C., Vastbinder, M.B., Koolen, S.L.W., Jager, A., Mathijssen, R.H.J.
Publicado 2023